Functionally, through T cell-mediated cancer cell killing assays and PD-L1/PD-1 binding assays, we demonstrated that FAT4 overexpression in tumor cells significantly activated CTL activity by downregulating PD-L1 levels. This evidence concerns the gene CD274 and cancer.